This site is intended for healthcare professionals
  • Home
  • /
  • News
  • /
  • 2020
  • /
  • 02
  • /
  • Merck KGaA sells Allergopharma to Dermapharm

Merck KGaA sells Allergopharma to Dermapharm

Read time: 1 mins
Published:20th Feb 2020
Merck KGaA, a leading science and technology company, signed an agreement to sell its allergy business Allergopharma to Dermapharm Holding SE . The transaction, which is expected to close by the end of the second quarter 2020, is subject to regulatory approval and satisfaction of other customary closing conditions.
Type: industry

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.